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Abstract
Background: Control of sexually transmitted infections (STI) is a global public health priority. Despite the UK’s free,
confidential sexual health clinical services, those at greatest risk of STIs, including young people, report barriers to
use. These include: embarrassment regarding face-to-face consultations; the time-commitment needed to attend
clinic; privacy concerns (e.g. being seen attending clinic); and issues related to confidentiality.
A smartphone-enabled STI self-testing device, linked with online clinical care pathways for treatment, partner
notification, and disease surveillance, is being developed by the eSTI2 consortium. It is intended to benefit public
health, and could do so by increasing testing among populations which underutilise existing services and/or by
enabling rapid provision of effective treatment. We explored its acceptability among potential users.
Methods: In-depth interviews were conducted in 2012 with 25 sexually-experienced 16–24 year olds, recruited
from Further Education colleges in an urban, high STI prevalence area. Thematic analysis was undertaken.
Results: Nine females and 16 males participated. 21 self-defined as Black; three, mixed ethnicity; and one, Muslim/
Asian. 22 reported experience of STI testing, two reported previous STI diagnoses, and all had owned smartphones.
Participants expressed enthusiasm about the proposed service, and suggested that they and their peers would use
it and test more often if it were available. Utilizing sexual healthcare was perceived to be easier and faster with STI
self-testing and online clinical care, which facilitated concealment of STI testing from peers/family, and avoided
embarrassing face-to-face consultations. Despite these perceived advantages to privacy, new privacy concerns arose
regarding communications technology: principally the risk inherent in having evidence of STI testing or diagnosis
visible or retrievable on their phone. Some concerns arose regarding the proposed self-test’s accuracy, related to
self-operation and the technology’s novelty. Several expressed anxiety around the possibility of being diagnosed
and treated without any contact with healthcare professionals.
Conclusions: Remote STI self-testing and online care appealed to these young people. It addressed barriers they
associated with conventional STI services, thus may benefit public health through earlier detection and treatment.
Our findings underpin development of online care pathways, as part of ongoing research to create this complex
e-health intervention.
Keywords: Acceptability of healthcare, Clinical pathways, eHealth, Internet, Mobile health, Sexually transmitted
infections
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Background
Sexually transmitted infections (STI) are a major public
health issue in England, and young people are particu-
larly affected [1, 2]. STI services seek to identify, diag-
nose and treat people with these often asymptomatic
infections, in order to prevent transmission and minim-
ise medical complications associated with repeat and
long-term infection.
Young people’s high STI rates persist despite good
provision of confidential, free sexual healthcare in the
UK (including London, where our study took place),
through a range of specialist and community services,
and the National Chlamydia Screening Programme
(NCSP) for England’s sexually-active under-25s [1, 2].
Specialist genito-urinary medicine (GUM) clinics pro-
vide free testing and treatment for a comprehensive
range of STIs and HIV. Sexual health clinics specific-
ally for young people (e.g. Brook) provide free contra-
ceptive and sexual health services, with STI service
provision varying between clinics. STI testing is often
available through contraceptive clinics and general
practice, also without charge. Within the NCSP, free
screening for chlamydia is delivered through various
channels, including community and healthcare set-
tings, and via internet-ordered postal home-sampling
kits (a service which was widely-available in the years
leading up to our study [3]). Self-taken samples of
urine (for males) or vulvo-vaginal swabs (for females)
are sent to a laboratory for testing with the result
communicated some days after, typically by telephone
or text message (SMS).
Over the last decade there have been considerable
efforts to widen access to sexual health services by ex-
tended and weekend opening hours within specialist
services, delivered from National Health Service (NHS)
genitourinary medicine (GUM)/sexual health clinics.
These are open-access (can be used without referral),
offer comprehensive STI testing and account for the
majority of reported STI diagnoses [2]. However, STI
clinic attendance is viewed by some as stigmatising [4],
which negatively impacts upon expectations and experi-
ences of attending clinic [5]. General practitioners
(GPs) have been encouraged to take on greater roles in
sexual health but have been perceived to offer variable
quality, less confidential services [4, 6]. Across all set-
tings, young people report fear of judgment by staff,
and embarrassment, which can deter sexual healthcare-
seeking, with particular concerns regarding face-to-face
consultations [6]. Young people also report embarrass-
ment [7] and stigma [8] associated with accepting offers
of chlamydia screening even though this does not
require a consultation. Receiving chlamydia home-
sampling kits by post avoids face-to-face offers of
screening, but can compromise privacy [4].
Currently, reliable rapid point of care tests for many
STIs are unavailable, but could deliver benefits in terms
of reduced complications, from faster provision of treat-
ment in clinics [9, 10], and reduced transmission, since
sexual risk behaviour may continue while patients are
awaiting diagnosis and treatment [11, 12]. Such benefits
may also be derived from a rapid self-test, provided that
users who test positive are promptly and effectively
treated. The Electronic Self-testing Instruments for Sexu-
ally Transmitted Infections (eSTI2) consortium is devel-
oping an accurate, rapid smartphone-enabled diagnostic
self-test for multiple STIs, linked to online clinical
management pathways which would be designed to
provide safe, appropriate treatment and care. This com-
plex intervention makes use of young adults’ relatively
high use of internet [13] and smartphone technologies
[14]. It is envisaged that users would register (providing
information for public health surveillance), do the test,
receive their diagnosis and, if positive, provide medical
information to enable safe prescribing of appropriate
antibiotic treatment, all online via their smartphone. If
appropriate, antibiotic treatment could be posted to
them, or an electronic authorisation (“e-prescription”)
could allow collection from a pharmacy. For many
users, this whole process could take place ‘remotely’,
without seeing or speaking to healthcare professionals,
or attending clinical settings.
Smartphone-enabled STI self-testing, linked to online
clinical management pathways, is a unique and complex
intervention. Although some examples of online STI
care exist [3, 15–21] these only represent parts of the
remote online care pathway we propose, with limited in-
formation on acceptability. Qualitative research on the
acceptability of home self-testing [22] and internet use
in relation to STI testing [23–26] suggests that potential
users have reservations around safety, test reliability, on-
line privacy and confidentiality. Much of this research
[22–25] was conducted in the US and Canada (i.e. differ-
ing health service contexts), and findings may not be
transferable to our proposed intervention. Therefore,
formative research was needed to inform the develop-
ment of our proposed complex e-health intervention
[27–29], which is intended as an adjunct to existing ser-
vices (rather than a replacement) and which may reach
populations which under-use existing services.
In this study, we explored perceptions and acceptability
of remote STI self-testing and associated online care path-
ways to treatment (a hypothetical intervention), among
young people from an Inner-London locality with high
rates of STIs [30] and large populations of Black Caribbean
and African ethnic origin. As our study population reflects
public health need for STI services, and young urban popu-
lations may also be ‘early adopters’ of new technologies, we
considered them potential users of our novel intervention.
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This study took place early in the development of the
self-test and the online care pathways, and was part of a
programme of formative research which informed this
complex intervention’s development. Other formative re-
search considered user-interface design [31] and clinical
care quality and safety [32], which together with this
study led to a recent proof-of-concept study of an online
care pathway for chlamydia, with mixed-methods evalu-
ation. Survey research has provided indicative evidence
about the user population [33], and development of the
self-testing device [34] is ongoing.
Methods
Study design and population
Individual in-depth interviews were conducted with
young people, recruited from an Inner-London Further
Education (FE) college. In the UK, FE colleges provide
post-compulsory education for those aged 16 and older,
often vocational, and are distinct from Higher Education in-
stitutions – universities – which provide degree-level aca-
demic qualifications. People from lower socio-economic
groups are over-represented among FE college students.
Eligible students were aged 16–24 years, and self-reported
having had sex at least once.
Sampling and recruitment
A purposive sampling strategy [35] was used, with gen-
der and age-group as primary sampling criteria, and a
target of 24–36 interviews. We used the age-groups 16–
19 and 20–24 because experience with sex, and with
sexual healthcare and healthcare in general, are likely to
increase with increasing age. Furthermore these categor-
ies are similar to those used in national STI surveillance
data. Following an email sent on behalf of the re-
searchers to all students, and posters placed in the col-
lege, students were approached in college communal
areas by the interviewer, or referred to him by staff. The
interviewer explained to potential participants that the
study would involve a face-to-face interview with him,
which would last about an hour, to find out what they
thought about a new way of testing for STIs. Further de-
tails of the study were provided orally and in informa-
tion sheets.
Procedure
Interviews took place in private rooms at college sites.
One male interviewer (SF) conducted and audio-
recorded all interviews. The topic guide, described
briefly here, had been piloted, and was used flexibly and
revised iteratively between interviews. The interviewer
began by asking about participants’ experience with
smartphone technology, internet-use in relation to health,
and STI testing. First impressions of ‘testing for STIs
using your smartphone’ were explored. Then, participants
were provided with a brief description of the proposed
testing device and associated online care pathway, aided
by an animation (Additional file 1) which outlined stages a
user would potentially go through (operating the self-
testing device with a sample of urine or vaginal swab,
receiving their result, and if positive, an online consult-
ation, ‘e-prescription’, partner notification and sexual
health advice). The interviewer explained that the test was
still being developed, but that the animation showed what
it might be like. Few details were provided about the test
and online care pathway, for simplicity, and because of
uncertainties at this stage in intervention development.
The interviewer explained that obtaining treatment this
way would be safe for most people (but not what would
happen otherwise). Scenarios were used to explore accept-
ability and preferences of various stages, from self-testing,
through to receipt of treatment for those testing positive
(Additional file 2). Participants were asked for their under-
standing of ‘confidentiality’. Interviews explored accept-
ability of providing personal details, sexual history, and
medical information to verify treatment safety, using their
smartphone. Participants were asked if they would use the
service described and why (not). The interviewer, mindful
of his somewhat older age, status as a university researcher,
association with novel technology, and the implications of
these for social desirability bias in the views participants
might express, sought to lessen the social distance between
himself and participants by mirroring participants’ language
use, and emphasised that he was not developing the inter-
vention and so would not be offended if they did not like or
agree with some or all of the proposed format. The inter-
viewer kept field-notes, recording circumstances of recruit-
ment and impressions from interviews. Interviews lasted
29–75 min (mean: 53mins). Each participant received £15
in recognition of their time and contribution to the study.
Interviews focused on exploring novel aspects of the
proposed intervention; aspects that are established as
broadly acceptable or have become common practice
(e.g. self-sampling [36], receipt of STI test results by
text-message) were not explored. Details unknown at the
time of the interviews were also not explored unless
mentioned by interviewees (including: which infections
the device would detect – described by the interviewer
as chlamydia in the first instance ‘because it is an easier
infection to treat’, specific clinical and disease surveil-
lance information to be collected, cost, distribution, and
whether the device would be for single or repeat use).
These are being explored in ongoing research.
Analysis
A thematic analysis [37] was conducted by CA, using
NVivo software and paper charts. For data familiarisation,
transcripts were read repeatedly, alongside listening to re-
cordings and reading field-notes. A mixed inductive-
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deductive approach was used: identification of themes was
influenced by emergent and recurring issues in the data,
and by a priori issues relating to study aims. Individuals’
accounts of their views and experiences with existing STI
testing services, and with smartphones and the internet,
were used to contextualise their views on the novel
service. Analysis took place after data collection was
complete, meaning that initial findings could not be ex-
plored in subsequent interviews.
SF and MS, who were familiar with the entire dataset,
provided detailed feedback on CA’s draft analysis, for verifi-
cation of findings. Participants’ comments were not sought
on either the transcripts or study findings. This was imprac-
tical because of the end of the college’s academic year and
study timelines. We also had concerns for participants’
privacy if we contacted them about the study, given the
eligibility criteria and sensitive content of the interviews.
Results
Participants
Twenty-five interviews took place in Spring/Summer 2012
(Table 1). Interviewees were aged 16–23 years (mean:
19 years). The quota of 6–8 participants in each sex/age-
group category was not filled for older females (n= 2 partici-
pants) prior to the end of the college’s term.1 However CA
and (independently) MS, SF, LJS considered saturation to
have been reached within the total sample achieved (i.e. no
new findings emerged in later interviews). Due to the way re-
cruitment took place, the number approached who declined
participation (and their reasons) were not recorded. Two stu-
dents scheduled an interview but did not participate.
Participants’ accounts of their STI testing experience
ranged from a single chlamydia screen, to repeated com-
prehensive testing in sexual health clinics. Use of STI
testing in general practice and use of internet-ordered
home-sampling for chlamydia were also reported. Two
participants, both women, spontaneously mentioned that
they had previously been diagnosed with an STI (how-
ever this question was not asked of all participants).
Perceptions of self-testing with online care pathways, in
relation to barriers to use of existing sexual healthcare
Barriers to use of existing sexual healthcare discussed by
participants were consistent with those identified in the
Table 1 Participants’ characteristics
Characteristic Number
Asked by the interviewer before the interview:
Gender Female Male
Agea 16–17 3 2
18–19 4 6
20–21 2 4
22–23 0 4
Ethnicityb Black/Black British, African 10
Black/Black British, Caribbean 6
Black British 5
Mixed 3
Muslim/Asian 1
Self-defined sexual orientationb, c Straight 22
Bisexual 2
Gay 1
Current sexual partner/s Yes 15
No 9
‘it’s complicated’ 1
Reported during the interview:
STI testing experience Yes 22
No 3
Smartphone ownership Yes, at time of interview 22
Not currently, but has had (lost, in repair, broken) 3
Never had a smartphone 0
aFor sampling purposes, age-groups were 16–19 and 20–24 years, however no participants were aged 24 years
bSelf-defined by participants. Ethnicity categories were grouped by researchers
cAll three respondents self-identifying as bisexual or gay were female
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literature (see Introduction). We focus on perceptions of
how the proposed intervention might address barriers to
testing using existing services.
Making access to STI testing quicker, easier and more
convenient
Participants described smartphone-enabled self-testing
and online care pathways as making access to STI test-
ing and treatment easier and more convenient than
existing services. They associated self-testing with having
greater control over when and where they could test –
which they welcomed.
…you could be in the bath, be like using the toilet, and
be like, let me just get this real quick and do this real
quick. It’s… convenient, very convenient. That’s why I
like it (V, young man, 18–19 years old)
Often, participants assumed that the testing device
and online care pathway would be easy to use, though
some expressed concerns about operating the device or
completing lengthy online forms, emphasising the im-
portance of ease of use.
‘Faceless’ sexual healthcare
Some participants described how concerns about being
recognised by staff influenced their STI testing behav-
iour, and some of those with experience of sexual health
clinics described embarrassment around giving a sexual
history face-to-face. Self-testing and providing informa-
tion ‘facelessly’ online was advantageous for these
participants.
I would rather that ‘cause there’s not no one in front of
me like talking to me or looking at me… (C, young
woman, 18–19 years old)
Concealing use of sexual healthcare
Some male participants, in both age-groups, explained
how they did not mind others discovering their use of
sexual healthcare. However many, including all of the fe-
male participants, spoke of wanting to conceal their sex-
ual healthcare use from family and peers as it suggested
or revealed possible STI, risky sexual behaviour or that
they were sexually-active. This was described as a barrier
to using sexual health clinics: participants described how
they might seek ‘discreet places far away from home’ (F,
young woman, 16–17 years old), use internet-based
home-sampling, or ‘when you get outside you’ve kind
of got to look around and make sure no one sees you
and then quickly run in there’ (B, young woman, 18–
19 years old). Young women expressed particular con-
cern about the conclusions others might draw about
their sexual activity.
Participants welcomed the perceived greater ability
they would have to conceal their STI testing by using a
self-test, although there were concerns about the test de-
vice itself being concealable. There was also anxiety
around the presence and visibility of electronic evidence
of STI testing on the phone, for instance an app installed
on the phone. Related to this point, there was great vari-
ation in how privately people described keeping their
phones: ‘no one’s really going to look at your phone’ (G,
young woman, 18–19 years old), versus ‘youth now-
adays, yeah, we always have each other’s phones’ (Y,
young man, 20–21 years old).
Further perceptions about remote self-testing with online
care
In this section we describe perceptions about remote
self-testing with online care pathways, which informed
an understanding of the proposed intervention’s accept-
ability, and its development.
Speed of testing
Participants expressed varied views about the speed of
test-operation (in contrast with their universal interest
in rapid access to testing and - if positive - treatment).
Some expected a result within minutes, reasoning that
new technology ought to provide this; ‘everything is fast
now’ (M, young man, 18–19 years old). Others reasoned
that a rapid test might be less accurate: a tension
between their desire for dependable, yet rapid, results.
Those who had used internet-based home-sampling,
who described valuing avoiding clinic attendance and/or
face-to-face consultations, would rather their results
arrived faster than from home-sampling services but
accepted waiting days or a week. This suggests that
trade-offs exist between speed and privacy, and between
speed and perceived accuracy.
Self-testing with new technology versus professionals
testing using established technology
For some participants ‘a result is a result’ (S, young
man, 18–19 years old), assumed to be accurate; they
reasoned that clinics also tested urine, stored results
on a computer, and with such an important purpose,
the testing device would have been checked prior to
release. Others questioned the accuracy of results
from self-tests. Two main sources of doubt were
identified: the novel technology and self-operation.
Concerning the technology:
…this is still new. It has still little kinks to be found,
little things to be found. Whereas the clinic is
established, they are doing it there and then. But the
longer it is out, the more confidence I would get in the
technology. (V, young man, 18–19 years old)
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Participants often seemed not to have questioned the
accuracy of clinic-based tests, until the interviewer asked
whether they would trust the new test. Self-operated
technology was an issue for this young person:
…the clinic, doctors, they’re more professional. That’s
exactly what [people] would think because that’s what
I would think as well but I would still put trust in my
phone. (X, young man, 16–17 years old)
He went on to say ‘I’d rather get it off the doctor, cos
your phone could come back inconclusive.’ Even some of
those who said they would trust results from self-tests,
described repeat-testing or confirming results in clinic as
ways to allay concerns about accuracy. Participants ex-
plained that the accuracy of results was extremely
important:
…just don't let it go faulty […] That’s the most
important thing in the whole wide world (F, young
woman, 16–17 years old).
Personal support from healthcare professionals
There was a tension between participants’ preferences
for avoiding clinical contact when accessing testing, and
a desire, expressed by some, for contact with a health-
care professional if a positive result were received. Often
this was related to anxieties which participants explained
might not be addressed through an online service:
…I will be having thoughts running in my head, so I
wouldn’t even have time to go through the link [to
access treatment] ‘cause I think there would be tension
and pressure on me, so, yeah. (P, young man, 22–23
years old)
A telephone helpline was considered an acceptable
way of providing this human support.
If you have an infection it should give you information
but it should also give you like phone numbers that you
can call to talk to someone because at the end of the day
I see it as, if it’s something on your phone you don’t really
wanna read so much. But if you can talk to someone, not
a computer, someone real, then you’re most likely to
listen. (H, young woman, 18–19 years old)
Legitimacy and credibility
A basis in the NHS and association with medical profes-
sionals enhanced the perceived legitimacy of the pro-
posed service
That it’s part of the NHS? It makes me feel safe, it
makes me feel okay, because like NHS are there to help
us innit, like they’re there to help, to support us. (T,
young man, 20–21 years old)
For some, however, a basis in the NHS made little differ-
ence provided the service was private and confidential.2
Confidentiality, data security and trust
Participants were told that with the proposed interven-
tion, users would provide registration information prior
to testing. The confidential but not anonymous nature
of the service was accepted with varying degrees of
reluctance, on the basis that the NHS was trusted and
personal information was required to provide any neces-
sary treatment, for one’s own benefit. Participants’ views
revealed assumptions that data provided to an NHS
service were shared across the NHS, ‘the NHS knows
so much about you anyway…’ (Y, young man, 20–21
years old).
There was variation in the extent to which participants
trusted their smartphones and the internet, with regard
to confidentiality. Passwords, assurance that the app/
website was secure, and the legitimacy of the service
aided trust in data security.
Concealing evidence of an STI
Unsurprisingly, participants described the importance of
keeping an STI diagnosis secret. However with the pro-
posed intervention, they discussed how not only the re-
sults message, but an ‘e-prescription’ and other messages
(e.g. text message reminders to collect treatment) could
reveal their STI status, if seen by others. Similarly, pref-
erences for treatment access (collection from community
pharmacy using an ‘e-prescription’; or received by post)
reflected privacy concerns.
I don’t like going to the [sexual health] clinic and
coming out with prescriptions to be honest with you,
but pharmacy, that’s what they’re for. (G, young
woman, 18–19 years old, previous STI diagnosis)
Receiving treatment by post was perceived as more
convenient, but slower than pharmacy, with implications
for privacy dependent on living arrangements:
…post is alright too, but then again, because I don’t
live by myself, I live with my parents. Then, my mum
sometimes likes to open my letters (I, young woman,
20–21 years old)
Final word
Overall there was enthusiasm for this innovation: ‘Just
get it done quicker, just get it out there fast. Cos it sounds
good, so it should be out there’ (L, young man, 20–21
years old).
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Implications for development of the proposed
intervention
Table 2 presents tentative design recommendations, and
recommendations for further work to develop the pro-
posed intervention. For ease of reference to the analysis,
the same headings are used as above.
Discussion
Main findings
A novel proposal for remote online self-testing and
treatment for STIs was broadly acceptable to these
ethnic-minority young people from a high-prevalence
population. In deciding whether to use existing STI test-
ing services, and considering self-testing, participants
appeared to balance three main factors: speed, conveni-
ence and privacy. Remote self-testing was perceived to
maintain privacy by reducing the risk of peers and family
members discovering their use of sexual healthcare,
through avoiding sexual health clinic attendance, and by
avoiding potentially embarrassing face-to-face consulta-
tions. By reducing these privacy concerns, and facilitat-
ing access to testing, participants expressed that they
might be more likely to test, or test more often, if
remote self-testing were available.
New privacy concerns with this novel intervention
concerned electronic evidence of sexual healthcare use
or STI diagnosis visible on their phone, online data se-
curity, and postal provision of treatment. Participants
described ways they could manage these risks, and how
intervention design could assist with this, but some con-
sidered risks to online data security inevitable. Enthusi-
asm about the novel technology contrasted with some
participants’ doubts about the accuracy of a novel, rapid,
self-operated test, while accuracy of conventional testing
was not questioned. Several participants’ discomfort with
sexual health consultations contrasted with their antici-
pated needs if they received a positive result or had
particular concerns: to seek personalised support from
healthcare professionals. Credibility of remote self-
testing and online care, including data security, was en-
hanced by its association with healthcare professionals
and trusted NHS services.
Strengths and weaknesses of this study
Formative research is particularly important in the
development of complex interventions [27], especially in
e-health [28]. During development, qualitative research
can contribute to an intervention’s success by informing
Table 2 Recommendations for the development of STI self-testing within online care pathways
Theme Recommendations for development
Making access to STI testing quicker, easier and more
convenient
The amount of information users need to input should be kept to a minimum.a
The device should be easy to use.
‘Faceless’ sexual healthcare Face-to-face contact with health service staff should be minimised.b
Concealing use of sexual healthcare The self-testing device needs to look inconspicuous (size, appearance).
The content and sender name of electronic communications (text messages, emails)
should make no reference to STI testing or use of sexual healthcare.
An app downloaded to the phone may compromise privacy, so alternatives should
be explored.
Speed of testing The test should give results faster than conventional services, but not necessarily very
rapidly.c
Self-testing with new technology vs. professionals
testing using established technology
Accuracy of results is very important.
Accuracy is a concern with self-operation of novel testing technology (ways to increase
confidence in the accuracy of the device, and minimise wasteful repeat-testing, need
further exploration).
Personal support from healthcare professionals Optional support from a health professional should be available.d Given the concern for
privacy and convenience, this could be by telephone.
Legitimacy and credibility Confidentiality should be assured.
It should be clear to users that the service is part of the NHS.
Confidentiality, data security and trust It should be clear to users that the service is part of the NHS.
Passwords, assurances that the system is secure, and legitimacy (above) aid trust in data
security.
Concealing evidence of an STI The design of the device and care pathways should enable users to keep all evidence of
STI secret (including: results message, prescription, treatment)
Convenience/discretion of postal receipt of treatment was preferred by some, while others
preferred the speed and privacy (from household members) of collecting treatment from
community pharmacy.
aThis needs to be balanced with clinical and disease surveillance requirements
bWhere medically-appropriate for individuals, and preferred. See also ‘Personal support from healthcare professionals’
cDiverse views were expressed, with some perceiving a very fast result to be less accurate
dThe need for a helpline from a clinical perspective had already been established, but this research confirmed its importance to potential users and its role in
providing emotional support
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an understanding of user-behaviour [29], particularly
relevant for our intervention, which will be used re-
motely with minimal supervision. As well as informing
an understanding of perceptions and acceptability of the
proposed novel intervention, we made specific recom-
mendations for its development (Table 2). Several of
these were supported (and none were contradicted) by
related formative research [31, 32]. However, as this
study took place prior to the availability of the STI self-
testing device and operational online care pathways, we
relied on participants’ ability to understand and engage
with the hypothetical, novel intervention. To make it less
abstract we chose a study population among whom STI
testing was likely to be familiar, and the interviewer
showed an animation to help describe the planned inter-
vention. We decided against restricting recruitment to
people with previous STI testing experience or STI diag-
nosis, as we sought to include those who test infrequently
or not at all, who may experience more barriers to testing
via existing services. Despite the hypothetical topic, inter-
views gained rich, detailed accounts of perceptions of
smartphone-enabled self-testing, and although only two
had been treated for an STI, participants also engaged well
with the concept of treatment via an ‘e-prescription’.
However many interviewees found provision of treatment
to partners difficult to engage with, perhaps because this
topic was far from their personal experience and particu-
larly abstract (requiring them to imagine a partner and a
context in which STI transmission could have occurred,
as well as imagining having been diagnosed with an STI
following use of the novel self-test). For reasons of data
quality we have not presented findings on this topic.
Engagement with target audiences is recognised as an
important challenge to e-sexual health interventions
[38], which may be aided by incorporating potential
users’ views throughout development. The demographic
profile of our participants is close to that of those con-
sidered at elevated risk of STI, based on their age, ethni-
city and recruitment from an urban, deprived population
[2]; thus a key target group for provision of STI services,
for reasons of equity and public health need. However,
men who have sex with men (MSM), another important
risk group for STI, were not targeted for recruitment to
the current study because in this educational setting, we
did not wish to compromise the privacy of those not
‘out’ to their classmates. Recruitment of exclusively non-
White participants (Table 1) was unintentional, largely
reflecting the location and student population. (Some
White students were approached, but declined partici-
pation, with reasons unknown.) The sampling quota
for women aged 20–24 (6–8 participants) was not
filled (n = 2), with implications for analysis and inter-
pretation. Our findings suggest a gender difference in
the importance of concealing use of sexual healthcare,
but this may also be influenced by female partici-
pants’ young age profile, compared to male partici-
pants. This was the only clear difference between
men and women’s expressed views in relation to the
study topic (and there were no clear differences be-
tween age-groups), but had we achieved a stronger
sample we might have been able to explore age-group
and gender differences further.
In qualitative research, it is recognised that the inter-
viewer and participants’ shared or different characteris-
tics influence the data (as discussed in [39]). Data quality
is not necessarily considered to be compromised by hav-
ing a non-peer interviewer [40, 41] (e.g. a male inter-
viewing females). In this study it is encouraging that
although the same male interviewer conducted all of the
interviews on this sensitive topic, interviewees of both
genders discussed their views and experience of sexual
healthcare use freely, and the two interviewees who dis-
closed their previous STI diagnoses (without prompting)
were both female. We did not seek participants’ com-
ments on the transcripts, which could have increased
data quality, however all transcripts were checked
against the audio-recordings. Those interviewed, who
chose to participate in a study about sexual health, may
be particularly comfortable with STI testing and/or sex-
ual healthcare. However some had little experience of
testing, and some discussed their dislike of existing ser-
vices, so it is unclear what effect this may have had on
the data. Non-participants’ privacy concerns may be
greater than those discussed by participants, who chose
to participate in an interview where they discussed sex-
ual healthcare face-to-face.
As explained, we took steps to reduce social desirabil-
ity bias, but our study’s premise that STIs are a problem,
which can possibly be addressed through new services,
was evident in information provided to participants. This
may have prompted criticism of existing services. How-
ever, participants’ views on existing services reflected
those identified in the literature [4–8], and all partici-
pants expressed both positive and negative views about
aspects of the novel intervention, indicating critical
engagement.
Comparison of our findings with the published literature
We know of no other research exploring the acceptabil-
ity of remote self-testing linked with online care for
STIs, as our proposed intervention is unique. However,
our intervention does include some elements that have
undergone limited evaluation in other studies. Qualita-
tive research with US young women (conducted 2007–
08) reported reservations about internet-use in relation
to STI testing, including online privacy and data security
concerns, and lack of personal support [23], which fea-
ture far less in findings reported in similar qualitative
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research among Canadian young people [25]. Our study
echoed similar findings concerning desire for support
from healthcare professionals following a positive diagno-
sis. Although privacy from peers and family was discussed
as important by most participants (related to preferring to
self-test instead of attending a sexual health clinic, and
preferring discreet messaging) online privacy/confidential-
ity and security provoked fewer concerns. This possibly
reflects our sample’s smartphone ownership, and the con-
fidence in the NHS which they described.
Similarly to our findings, other online sexual health ser-
vices (internet-ordered home-sampling [23]; downloadable
laboratory forms for STI testing without face-to-face
consultations [24, 25]) have been perceived positively for
their convenience and privacy. US clinic-attenders’ views
(focus-groups, 2008–09) on rapid home self-tests for STIs
include concerns regarding accuracy and self-operation,
and non-immediate treatment access [22]. A US survey on
the acceptability of home-sampling among sexual minor-
ity youth found similar concerns about test accuracy and
home self-sampling [42]. Our participants also expressed
concerns around accuracy and self-operation, with linkage
to treatment perceived positively.
Meaning and implications of our study
Our findings suggest that remote self-testing and online
care pathways, as described here, would be acceptable as
a complement to existing STI services, provided that
personal support from healthcare professionals is avail-
able to those testing remotely, and accuracy concerns
are addressed.
In addition to findings from this (and other) formative
research, intervention design must also take account
what is technically possible, clinical safety, and public
health concerns (see Further Research, below). In the de-
velopment of the proposed intervention, we need to
consider that young people may desire to keep secret
not only any STI diagnosis/es, but their sexual health-
care use. Regarding ‘evidence’ of sexual healthcare use
on users’ smartphones, care needs to be taken regarding
name of the sender and wording of text messages, while
web-apps (which are not downloaded or installed to
users’ phones) are an alternative to native apps, and
NHS branding may confer trustworthiness. For speed
and privacy from household members, collection of
medication via ‘e-prescription’ from community pharma-
cies may be more suitable than postal treatment in this
young population, depending, of course, on the STI and
the nature of the recommended treatment.
Innovations in sexual health clinics, e.g. ‘no-talk’ test-
ing with registration/clinical information provided on
paper or electronic forms (e.g. touch-screens) [43–45],
may already meet some of young people’s access and
privacy needs. However our findings suggest that by
removing the need to attend sexual health clinics (for
many patients), our intervention may overcome further
barriers to sexual healthcare use, resulting in earlier de-
tection of STI. Provided users are able to use the care
pathway to access treatment promptly, public health
benefits would result from decreased STI transmission
and decreased complications of long-term infection.
Unanswered questions and future research
Findings from our study, together with other formative
research [31, 32], have informed intervention design. In
terms of its accessibility, potential users’ health literacy
and use of appropriate terminology are being considered
in its development. Building on this programme of re-
search, online care pathways for chlamydia treatment
[32] were recently piloted for feasibility, acceptability
and preliminary evidence of effectiveness, and qualitative
research was conducted with people who used these on-
line pathways, informed by the findings we present here.
Development of the rapid testing device is ongoing.
Future research must continue to explore the accept-
ability and feasibility of remote self-testing for STIs and
online clinical care pathways, among young people and
other potential user-groups (such as MSM, other age-
groups and ethnicities), and identify barriers and facilita-
tors to implementation, including costs to users and to
the health service. Further research could also explore
how acceptability varies between different STIs and when
testing for multiple infections. A recent exploratory pilot
study about the feasibility, acceptability and safety of an
online clinical care pathway for chlamydia was conducted,
using mixed-methods (articles in preparation). Sampling
limitations of the study reported in this article were ad-
dressed in this recent research, which will give us greater
scope to explore the role of gender and other factors.
Conclusions
Our research has informed intervention design, and
identified concerns that can be addressed, or need to be
explored further. By reducing or removing barriers that
participating young people associated with conventional
STI testing, our findings suggest that this complex inter-
vention may enable earlier detection and treatment of
STIs, thus delivering public health benefit through re-
duced transmission and reduced complications of infec-
tions. Remote STI testing may be a useful adjunct to our
repertoire of STI services, ideally integrated within on-
line clinical pathways embedded within existing sexual
healthcare provision.
Endnotes
1While A-level courses at the college are taken by
younger students of both genders, technical/vocational
courses at the college are traditionally gendered (e.g.
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construction, electronics, beauty). The interviewer en-
countered more male students than female in the 20–24
age-group on the college campus which taught voca-
tional courses. He therefore asked staff at both campuses
to direct him to the locations where there were more
20–24 year old females. Unfortunately he only received
this information one week before the end of the aca-
demic year, which limited his opportunities to recruit.
The high level saturation within the sample achieved,
and requirements for the interviews to inform the next
phase of our research, led to our decision not to recruit
further participants when the college re-opened.
2During the interviews, participants were asked their un-
derstanding of ‘confidentiality’. Despite the interviewer’s ex-
planation during consent-taking, several could not define
the term, and several misdefined it as confidence, referring
to self-confidence or confidence/trust in healthcare. Partici-
pants tended to use the broader term ‘private’ to describe
how they wanted their information to be held, and services
to be. We use the standard definition of confidentiality, ra-
ther than how participants used the term.
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